Poly Medicure Management

Management criteria checks 2/4

Poly Medicure's CEO is Himanshu Baid, appointed in Sep 1995, has a tenure of 28.67 years. total yearly compensation is ₹130.06M, comprised of 42.3% salary and 57.7% bonuses, including company stock and options. directly owns 12.24% of the company’s shares, worth ₹19.27B. The average tenure of the management team and the board of directors is 5.9 years and 10.9 years respectively.

Key information

Himanshu Baid

Chief executive officer

₹130.1m

Total compensation

CEO salary percentage	42.3%
CEO tenure	28.7yrs
CEO ownership	12.2%
Management average tenure	5.9yrs
Board average tenure	10.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Himanshu Baid's remuneration changed compared to Poly Medicure's earnings?
Date	Total Compensation	Salary	Company Earnings
Dec 31 2023	n/a	n/a	₹2b
Sep 30 2023	n/a	n/a	₹2b
Jun 30 2023	n/a	n/a	₹2b
Mar 31 2023	₹130m	₹55m	₹2b
Dec 31 2022	n/a	n/a	₹2b
Sep 30 2022	n/a	n/a	₹1b
Jun 30 2022	n/a	n/a	₹1b
Mar 31 2022	₹107m	₹49m	₹1b
Dec 31 2021	n/a	n/a	₹1b
Sep 30 2021	n/a	n/a	₹1b
Jun 30 2021	n/a	n/a	₹1b
Mar 31 2021	₹92m	₹44m	₹1b
Dec 31 2020	n/a	n/a	₹1b
Sep 30 2020	n/a	n/a	₹1b
Jun 30 2020	n/a	n/a	₹1b
Mar 31 2020	₹62m	₹35m	₹959m
Dec 31 2019	n/a	n/a	₹947m
Sep 30 2019	n/a	n/a	₹858m
Jun 30 2019	n/a	n/a	₹719m
Mar 31 2019	₹44m	₹14m	₹654m
Mar 31 2018	₹41m	₹14m	₹706m

Compensation vs Market: Himanshu's total compensation ($USD1.56M) is above average for companies of similar size in the Indian market ($USD433.43K).

Compensation vs Earnings: Himanshu's compensation has increased by more than 20% in the past year.

CEO

Himanshu Baid (55 yo)

28.7yrs

Tenure

₹130,063,000

Compensation

Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Himanshu Baid	CEO, MD & Director	28.7yrs	₹130.06m	12.24% ₹ 19.3b
Jugal Baid	Founder & Non Executive Director	no data	₹1.43m	2.38% ₹ 3.7b
Naresh Vijayvergiya	Chief Financial Officer	2.8yrs	₹9.90m	no data
Avinash Chandra	Company Secretary & Compliance Officer	9yrs	₹1.67m	no data
Rishi Baid	Joint MD & Executive Director	no data	₹124.73m	13.07% ₹ 20.6b
Vishal Baid	President of Corporate Sales & Marketing	2.1yrs	₹17.15m	1.75% ₹ 2.8b
P. Rastogi	Assistant Vice President of Finance & Accounts	no data	no data	no data
Hemant Bhalla	Senior Vice President of Domestic Sales & Marketing	no data	₹5.79m	no data
Pankaj Gupta	President of R&D	no data	₹5.61m	no data
Manish Sardana	President of Sales & Marketing - India	no data	₹8.61m	no data

5.9yrs

Average Tenure

55yo

Average Age

Experienced Management: 531768's management team is seasoned and experienced (5.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Himanshu Baid	CEO, MD & Director	29.2yrs	₹130.06m	12.24% ₹ 19.3b
Jugal Baid	Founder & Non Executive Director	29.2yrs	₹1.43m	2.38% ₹ 3.7b
Rishi Baid	Joint MD & Executive Director	29.2yrs	₹124.73m	13.07% ₹ 20.6b
Amit Khosla	Non-Executive Independent Director	3.9yrs	₹1.58m	no data
Devendra Mehta	Non-Executive Independent Chairman	19yrs	₹1.60m	no data
Prakash Surana	Non-Executive Independent Director	26.7yrs	₹1.40m	0.0011% ₹ 1.8m
Mukulika Baid	Non-Executive Director	9.8yrs	₹1.43m	3.19% ₹ 5.0b
Shailendra Mehta	Non-Executive Independent Director	12yrs	₹1.55m	no data
Sonal Mattoo	Non-Executive Independent Director	3.8yrs	₹1.48m	0.000040% ₹ 63.0k
Sandeep Bhargava	Non-Executive Independent Director	7.3yrs	₹1.45m	no data
Alessandro Balboni	Non-Executive Non Independent Director	6yrs	no data	no data
Ambrish Mithal	Independent Director	2.1yrs	₹900.00k	no data

10.9yrs

Average Tenure

63yo

Average Age

Experienced Board: 531768's board of directors are seasoned and experienced ( 10.9 years average tenure).

Poly Medicure Management

Management criteria checks 2/4

Key information

Recent management updates

Poly Medicure Limited, Annual General Meeting, Sep 28, 2023

Insufficient new directors

Joint MD & Executive Director recently sold ₹146m worth of stock

Poly Medicure Limited Appoints Ambrish Mithal as Independent Director

Poly Medicure Limited Appoints Ravi Prakash as Deputy Company Secretary and Compliance Officer

Joint MD & Executive Director recently sold ₹8.5m worth of stock

Recent updates

Price target increased by 9.4% to ₹1,718

Price target increased by 9.4% to ₹1,718

Price target increased by 7.5% to ₹1,620

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Poly Medicure Limited to Report Q3, 2024 Results on Jan 31, 2024

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Poly Medicure Limited to Report Q2, 2024 Results on Nov 04, 2023

Upcoming dividend of ₹3.00 per share at 0.2% yield

Poly Medicure Limited, Annual General Meeting, Sep 28, 2023

Insufficient new directors

Joint MD & Executive Director recently sold ₹146m worth of stock

Price target increased by 18% to ₹1,299

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 18%

Poly Medicure Limited to Report Q1, 2024 Results on Aug 07, 2023

Investor sentiment improves as stock rises 16%

Full year 2023 earnings: EPS exceeds analyst expectations

Poly Medicure Limited Proposes Dividend for the Financial Year 2022-23

Third quarter 2023 earnings released: EPS: ₹5.21 (vs ₹3.60 in 3Q 2022)

Poly Medicure Limited to Report Q3, 2023 Results on Jan 28, 2023

Price target increased to ₹1,021

Price target increased to ₹1,021

Second quarter 2023 earnings released: EPS: ₹4.53 (vs ₹3.99 in 2Q 2022)

Poly Medicure Limited to Report Q2, 2023 Results on Nov 04, 2022

Investor sentiment improved over the past week

Poly Medicure Limited Appoints Ambrish Mithal as Independent Director

Upcoming dividend of ₹2.50 per share

Poly Medicure Limited Recommends Dividend for the Year Ended March 31, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹2.81 (vs ₹3.92 in 1Q 2022)

Poly Medicure Limited to Report Q1, 2023 Results on Aug 04, 2022

Investor sentiment improved over the past week

Price target decreased to ₹959

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Poly Medicure Limited Appoints Ravi Prakash as Deputy Company Secretary and Compliance Officer

Price target decreased to ₹1,045

Joint MD & Executive Director recently sold ₹8.5m worth of stock

Price target decreased to ₹1,041

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Second quarter 2022 earnings released: EPS ₹3.99 (vs ₹3.97 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹3.92 (vs ₹3.03 in 1Q 2021)

Chief Financial Officer Jas Karan Oswal has left the company

Full year 2021 earnings released: EPS ₹15.25 (vs ₹10.87 in FY 2020)

Poly Medicure Limited Recommends Dividend for the Year 2020-2021

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day high: ₹756

Investor sentiment improved over the past week

New 90-day high: ₹555

Third quarter 2021 earnings released: EPS ₹4.00 (vs ₹2.83 in 3Q 2020)

Poly Medicure Limited to Report Q3, 2021 Results on Jan 27, 2021

New 90-day high: ₹537

New 90-day high: ₹513

First half earnings released

New 90-day high: ₹510

New 90-day high - ₹473

New 90-day high - ₹412

CEO Compensation Analysis

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age